The Chief Executive Officer of ReNeuron Group (Other OTC: RNUGF) is Buying Shares

By Carrie Williams

Today, the Chief Executive Officer of ReNeuron Group (RNUGFResearch Report), Olav Hellebø, bought shares of RNUGF for $20K.

In addition to Olav Hellebø, 5 other RNUGF executives reported Buy trades in the last month. Following this transaction Olav Hellebø’s holding in the company was increased by 4% to a total of $905.4K.

See today’s analyst top recommended stocks >>

Currently, ReNeuron Group has an average volume of . The company has a one-year high of $2.32 and a one-year low of $0.95.

Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

ReNeuron Group Plc engages in the development of novel cell based therapies that target significant areas of unmet medical need. It develops its core stem cell assets such as CTX neural cell line and human retinal progenitor cells. The company was founded by John David Sinden in 1997 and is headquartered in Pencoed, the United Kingdom.